Los Angeles Capital Management LLC Sells 1,780 Shares of Agilent Technologies, Inc. (NYSE:A)

Los Angeles Capital Management LLC trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 54.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,509 shares of the medical research company’s stock after selling 1,780 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Agilent Technologies were worth $224,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Livelsberger Financial Advisory bought a new position in Agilent Technologies in the third quarter worth about $28,000. Crewe Advisors LLC raised its stake in shares of Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after acquiring an additional 101 shares in the last quarter. Ridgewood Investments LLC purchased a new stake in Agilent Technologies during the second quarter valued at approximately $29,000. Fortitude Family Office LLC boosted its stake in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC purchased a new position in Agilent Technologies in the second quarter worth $39,000.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The trade was a 7.51 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,995 shares of company stock worth $1,739,510 in the last three months.

Agilent Technologies Trading Down 0.1 %

NYSE A opened at $126.92 on Tuesday. Agilent Technologies, Inc. has a 1 year low of $112.39 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The company has a market capitalization of $36.47 billion, a PE ratio of 26.33, a P/E/G ratio of 5.59 and a beta of 1.07. The company has a fifty day moving average of $138.50 and a 200 day moving average of $137.92.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company’s revenue was down 5.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.43 earnings per share. Research analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were paid a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.74%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 19.50%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on A. Wells Fargo & Company assumed coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price objective for the company. Citigroup increased their price target on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. TD Cowen increased their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Finally, Evercore ISI lifted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $144.36.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.